Showing results (371-380 of 793) with videos related to

Sort By:
Pageof 80
The Journal of Infectious Diseases|November 1, 1995
A randomized trial of the activity and safety of Ro 24-7429 (Tat antagonist) versus nucleoside for human immunodeficiency virus infection. The AIDS Clinical Trials Group 213 TeamR H Haubrich, C Flexner, M M Lederman, et al.
The New England Journal of Medicine|August 27, 1992
A controlled trial comparing continued zidovudine with didanosine in human immunodeficiency virus infection. The NIAID AIDS Clinical Trials GroupJ O Kahn, S W Lagakos, D D Richman, et al.
Antiviral Therapy|February 6, 2004
Nucleoside and nucleotide analogue reverse transcriptase inhibitors: a clinical review of antiretroviral resistanceJoel E Gallant, Peter Z Gerondelis, Mark A Wainberg, et al.
The Journal of Biological Chemistry|August 5, 1993
Amino acid substitutions in HIV-1 reverse transcriptase with corresponding residues from HIV-2. Effect on kinetic constants and inhibition by non-nucleoside analogsA Bacolla, C K Shih, J M Rose, et al.
Medical Care|August 11, 1991
A health status questionnaire using 30 items from the Medical Outcomes Study. Preliminary validation in persons with early HIV infectionA W Wu, H R Rubin, W C Mathews, et al.
Nature|September 6, 1990
Inhibition of HIV replication by pokeweed antiviral protein targeted to CD4+ cells by monoclonal antibodiesJ M Zarling, P A Moran, O Haffar, et al.
Journal of Clinical Microbiology|August 1, 1987
Antibody to a synthetic oligopeptide in subjects at risk for human immunodeficiency virus infectionR S Smith, R B Naso, J Rosen, et al.
Plos Pathogens|November 30, 2016
Transcriptomic Analysis Implicates the p53 Signaling Pathway in the Establishment of HIV-1 Latency in Central Memory CD4 T Cells in an In Vitro ModelCory H White, Bastiaan Moesker, Nadejda Beliakova-Bethell, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 21, 2016
Investigating the poor outcomes of BRAF-mutant advanced colorectal cancer: analysis from 2530 patients in randomised clinical trialsJ F Seligmann, D Fisher, C G Smith, et al.
JAMA|September 7, 1984
Double-blind placebo-controlled trial of oral acyclovir in first-episode genital herpes simplex virus infectionG J Mertz, C W Critchlow, J Benedetti, et al.
Pageof 80